Note 10 - Business Segment Reporting

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

10. Business Segment Reporting

The Company manages its operations as

one

segment, drug testing services. As a result, the financial information disclosed herein materially represents all of the financial information related to the Company's principal operating segment. All Brazil sales are through

one

independent distributor. The Company's revenues by geographic region are as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2020		2019		2020		2019
Consolidated Revenue:
United States	$	3,125	$	6,807	$	9,466	$	13,867
Brazil		164		2,358		1,145		5,001
Other		25		124		240		243
Total Revenue	$	3,314	$	9,289	$	10,851	$	19,111